This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.
Research
Latest papers
A Double-Edged Sword: How Clinical Context Shapes Clinicians' Perceptions of Parental Religion in Paediatric Critical Care.
Acta paediatrica (Oslo, Norway : 1992) · 2026
Defining the window of opportunity for post-transplant ThINKK therapy and TRAIL as a biomarker of NK cell response.
Cytotherapy · 2026 · senior author
Training healthcare professionals in hypnosis-derived communication to mitigate procedural pain in children.
Scientific reports · 2025
Latest funding
- $100,000
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
CIHR · 2023 · Nominated PI
- $100,000
Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers
CIHR · 2022 · Nominated PI
- $673,200
Adoptive transfers of in vitro differentiated plasmacytoid dendritic cells to prevent acute lymphoblastic leukemia relapse: mechanisms and biomarkers of sensitivity
CIHR · 2019 · Nominated PI
53 publications.
A Double-Edged Sword: How Clinical Context Shapes Clinicians' Perceptions of Parental Religion in Paediatric Critical Care.
Lavoie B, Gaucher N, Lacharité F, Roumeliotis N, Duval M, Levasseur MC, Weinstock D, Marquis MA, Payot A
Defining the window of opportunity for post-transplant ThINKK therapy and TRAIL as a biomarker of NK cell response.
Ollame-Omvane É, Khemis LB, Cordeiro P, Galopin M, Frizot M, Leveille K, Usmani N, Teira P, Cellot S, Bittencourt H, Herblot S, Duval M
Training healthcare professionals in hypnosis-derived communication to mitigate procedural pain in children.
Sultan S, Duval M, Aramideh J, Bőthe B, Latendresse A, Bedu M, Lévesque A, Rondeau É, Le May S, Moussa A, Bourque CJ, Tsimicalis A, Doré Bergeron MJ, Trottier ÉD, Gravel J, Ogez D
Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings.
Poirier N, Paquin V, Leclerc S, Lisi V, Marmolejo C, Affia H, Cordeiro P, Théorêt Y, Haddad E, Andelfinger G, Lavallée VP, Duval M, Herblot S
Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion.
Beaudry A, Jacques-Ricard S, Darracq A, Sgarioto N, Garcia A, García TR, Lemieux W, Béland K, Haddad E, Cordeiro P, Duval M, McGraw S, Richer C, Caron M, Marois F, St-Onge P, Sinnett D, Banquy X, Raynal NJ
Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis.
Beaufils C, Proulx C, Blincoe A, Teira P, Bittencourt H, Cellot S, Duval M, Morin MP, De Bruycker JJ, Couture J, Samaan K, Decaluwe H, Kleiber N, El-Jalbout R, Touzot F, Haddad E, Barsalou J
Cancer-related fatigue: scoping review to synthesize a definition for childhood cancer survivors
Levesque A, Caru M, Duval M, Laverdière C, Marjerrison S, Sultan S
Quality of life in childhood advanced cancer: from conceptualization to assessment with the Advance QoL tool.
Avoine-Blondin J, Dumont É, Marquis MA, Duval M, Sultan S
Cancer-related fatigue in childhood cancer survivors: A systematic scoping review on contributors of fatigue and how they are targeted by non-pharmacological interventions
Levesque A, Caru M, Duval M, Laverdière C, Marjerrison S, Sultan S
Intrabone infusion for allogeneic umbilical cord blood transplantation in children.
Vairy S, Louis I, Vachon MF, Richer J, Teira P, Cellot S, Villeneuve E, Haddad E, Duval M, Bittencourt H
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
Principal investigators: Duval, Michel
Keywords: Adoptive Immunotherapy; Cell Therapy Manufacturing; Childhood Cancer; First-In-Human Clinical Trial; Hematopoietic Stem Cell Transplantation; Nk Cell-Based Immunotherapy
Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers
Principal investigators: Duval, Michel
Keywords: Adoptive Immunotherapy; Cell Therapy Manufacturing; Childhood Cancer; First-In-Human Clinical Trial; Hematopoietic Stem Cell Transplantation; Nk Cell-Based Immunotherapy
Adoptive transfers of in vitro differentiated plasmacytoid dendritic cells to prevent acute lymphoblastic leukemia relapse: mechanisms and biomarkers of sensitivity
Principal investigators: Duval, Michel
Keywords: Acute Lymphoblastic Leukemia; Apoptosis Pathways; Biomarkers Of Sensitivity; Cancer Immunotherapy; Hematopoietic Stem Cell Transplantation; Natural Killer Cells; Plasmacytoid Dendritic Cells
Toward the cure of neuroblastoma: innovative immunotherapeutic approaches
Principal investigators: Duval, Michel; Decaluwe, Hélène; Haddad, Elie; Raynal, Noël J
Keywords: Cord Blood Transplantation; Dendritic Cells; Epigenetic Therapy; Immunological Checkpoint Blockade; Immunotherapy; Mouse Model Of Cord Blood Transplantation; Mouse Model Of Human Neuroblastoma Xenograft; Natural Killer Cells; Relasped/Refractory Neuroblastoma
Preclinical models of natural killer cell-based immunotherapy to cure refractory childhood acute lymphoblastic leukemia
Principal investigators: Duval, Michel; Haddad, Elie
Keywords: Childhood Leukemia; Cord Blood Transplantation; Cytokine Induced Killer Cells; Dendritic Cells; Immunotherapy; Mouse Model Of Cord Blood Transplantation; Mouse Model Of Human Leukemia Xenograft; Natural Killer Cells
Transfusion-related Epstein-Barr Virus (EBV) infection among allogeneic stem cell transplant pediatric recipients: a multicenter prospective cohort study (TREASuRE study)
Principal investigators: Trottier, Helen
Keywords: Blood Products; Epidemiology; Epstein-Barr Virus; Immunosuppression; Transfusion; Viral Transmission
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pediatrics
- Microbiologie et immunologie
- Medical Intensive Care Unit
- Pharmacologie - Physiologie
- Médecine sociale et préventive
- Microbiology and Immunology
- Pathology and Laboratory Medicine
- Other
Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Elie Haddad
Pediatrics
8 shared papers, latest 2024
Sonia Cellot
Faculty
7 shared papers, latest 2026
Daniel Sinnett
Pharmacologie - Physiologie
5 shared papers, latest 2023
Hugo Soudeyns
Microbiologie et immunologie
4 shared papers, latest 2012
Jacques Lacroix
Medical Intensive Care Unit
4 shared papers, latest 2021
Marisa Tucci
Medical Intensive Care Unit
4 shared papers, latest 2021
Helen Trottier
Médecine sociale et préventive
4 shared papers, latest 2021
Victor Lewis
Pediatrics
3 shared papers, latest 2021
Suzanne Vercauteren
Pathology and Laboratory Medicine
2 shared papers, latest 2021
Carolina Alfieri
Microbiology and Immunology
2 shared papers, latest 2021
Ali Ahmad
Faculty
2 shared papers, latest 2017
Stacey Marjerrison
Pediatrics
2 shared papers, latest 2023
Serge McGraw
Obstétrique et gynécologie
1 shared papers, latest 2023
Catherine Goudie
Faculty
1 shared papers, latest 2019
Xavier Banquy
Faculty
1 shared papers, latest 2023
Nadia Roumeliotis
Pediatrics
1 shared papers, latest 2026
Gregor Andelfinger
Pédiatrie
1 shared papers, latest 2024
Catherine Malboeuf-Hurtubise
Educational and Counselling Psychology
1 shared papers, latest 2016
Fabien Touzot
Microbiologie et immunologie
1 shared papers, latest 2023
Argerie Tsimicalis
Faculty
1 shared papers, latest 2025
Jocelyn Gravel
Faculty
1 shared papers, latest 2025
David Ogez
Faculty
1 shared papers, latest 2025
Daniel Weinstock
Family Medicine
1 shared papers, latest 2026
Caroline Diorio
Social and Preventive Medicine
1 shared papers, latest 2017
Denis Leclerc
Microbiologie et d'infectiologie
1 shared papers, latest 2018
Lionel Carmant
Faculty
1 shared papers, latest 2013
Devendra Amre
Faculty
1 shared papers, latest 2017
Nada Jabado
Pediatrics
1 shared papers, latest 2019
Sylvie Le May
Faculty
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.